CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 233 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $596,517 | +12.1% | 51,028 | +28.9% | 0.00% | – |
Q2 2023 | $532,143 | -17.2% | 39,594 | +2.1% | 0.00% | – |
Q1 2023 | $642,823 | -7.1% | 38,771 | +4.2% | 0.00% | – |
Q4 2022 | $692,199 | +41.6% | 37,215 | -2.4% | 0.00% | – |
Q3 2022 | $488,977 | +79.2% | 38,112 | -2.1% | 0.00% | – |
Q2 2022 | $272,899 | -18.0% | 38,930 | -3.0% | 0.00% | – |
Q1 2022 | $332,785 | -4.6% | 40,143 | -22.1% | 0.00% | – |
Q4 2021 | $349,000 | +21.6% | 51,530 | -4.9% | 0.00% | – |
Q3 2021 | $287,000 | -14.1% | 54,175 | -6.8% | 0.00% | – |
Q2 2021 | $334,000 | +17.6% | 58,143 | -5.6% | 0.00% | – |
Q1 2021 | $284,000 | +40.6% | 61,610 | +2.0% | 0.00% | – |
Q4 2020 | $202,000 | +14.8% | 60,392 | +2.0% | 0.00% | – |
Q3 2020 | $176,000 | -34.8% | 59,227 | 0.0% | 0.00% | – |
Q2 2020 | $270,000 | +12.0% | 59,227 | -5.2% | 0.00% | – |
Q1 2020 | $241,000 | +10.0% | 62,505 | +6.8% | 0.00% | – |
Q4 2019 | $219,000 | -32.2% | 58,518 | -4.6% | 0.00% | – |
Q3 2019 | $323,000 | +32.9% | 61,335 | -3.0% | 0.00% | – |
Q2 2019 | $243,000 | -28.9% | 63,211 | -5.8% | 0.00% | – |
Q1 2019 | $342,000 | +180.3% | 67,107 | +5.8% | 0.00% | – |
Q4 2018 | $122,000 | -52.7% | 63,405 | -7.1% | 0.00% | – |
Q3 2018 | $258,000 | +6.6% | 68,237 | -12.1% | 0.00% | – |
Q2 2018 | $242,000 | +49.4% | 77,635 | +14.1% | 0.00% | – |
Q1 2018 | $162,000 | -26.7% | 68,058 | +20.4% | 0.00% | – |
Q4 2017 | $221,000 | +44.4% | 56,542 | -6.8% | 0.00% | – |
Q3 2017 | $153,000 | -12.6% | 60,682 | -3.9% | 0.00% | – |
Q2 2017 | $175,000 | +2816.7% | 63,114 | +1861.3% | 0.00% | – |
Q1 2017 | $6,000 | +100.0% | 3,218 | 0.0% | 0.00% | – |
Q4 2016 | $3,000 | -25.0% | 3,218 | 0.0% | 0.00% | – |
Q3 2016 | $4,000 | +100.0% | 3,218 | 0.0% | 0.00% | – |
Q2 2016 | $2,000 | -96.7% | 3,218 | -94.1% | 0.00% | – |
Q1 2016 | $60,000 | -50.4% | 54,176 | +9.3% | 0.00% | – |
Q4 2015 | $121,000 | -18.2% | 49,577 | 0.0% | 0.00% | – |
Q3 2015 | $148,000 | -27.8% | 49,577 | 0.0% | 0.00% | – |
Q2 2015 | $205,000 | +10150.0% | 49,577 | +8149.1% | 0.00% | – |
Q3 2014 | $2,000 | 0.0% | 601 | 0.0% | 0.00% | – |
Q2 2014 | $2,000 | +100.0% | 601 | 0.0% | 0.00% | – |
Q1 2014 | $1,000 | – | 601 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |